NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

整形外科用生醫材料的中國市場 (2020-2026年):移植骨替代物、玻尿酸關節內補充藥、成長因素 - MedSuite

Orthopedic Biomaterials Market Report Suite - China - 2020-2026 - Medsuite

出版商 iData Research Inc. 商品編碼 928406
出版日期 內容資訊 英文 131 Pages
商品交期: 最快1-2個工作天內
價格
整形外科用生醫材料的中國市場 (2020-2026年):移植骨替代物、玻尿酸關節內補充藥、成長因素 - MedSuite Orthopedic Biomaterials Market Report Suite - China - 2020-2026 - Medsuite
出版日期: 2020年03月01日內容資訊: 英文 131 Pages
簡介

本報告提供中國的整形外科用生醫材料市場相關調查,市場趨勢,手術數量,各產品市場區隔市場上概況、成長促進因素、阻礙成長的要素、競爭情形等系統性資訊。

目錄

圖表

摘要整理

  • 中國的整形外科用生醫材料市場市場概要
  • 競爭分析
  • 市場趨勢
  • 主要市場開發
  • 對象手術
  • 對象市場
  • 主要報告的更新
  • 版本履歷

歐洲的神經調節,神經血管及神經外科設備市場概要

競爭分析

市場趨勢

市場開發

對象手術

對象市場

主要報告的更新

版本履歷

調查方法

  • 調查範圍
  • IDATA的9等級的調查手法
  • 階段1:計劃的開始和隊伍的選擇
  • 階段2:數據系統的準備及2次調查的實施
  • 階段3:採訪的準備及問卷調查的設計
  • 階段4: 1次調查的實施
  • 階段5: 調查分析 - 基準估計的確立
  • 階段6:市場預測及分析
  • 階段7:策略性尋找機會
  • 階段8:最後檢討及市場公佈
  • 階段9:客戶回饋及市場監測

中國的整形外科生物材料市場市場概要

  • 簡介
    • 移植骨替代物
    • 玻尿酸關節內補充藥
    • 成長因素
  • 匯率
  • 市場概要
  • 趨勢分析
  • 促進市場成長要素與阻礙因素
    • 促進因素
    • 阻礙因素
  • 競爭分析
  • 合併和收購

治療數量

  • 骨移植片替代物的治療數量
    • 各材料
    • 各適應症
  • 玻尿酸關節內補充藥的治療數量
    • 各注射循環
  • 整形外科用成長因素的治療數量
    • 治療數量

移植骨替代物市場

  • 簡介
  • 市場概要
    • 各材料
    • 各適應症
  • 市場分析、預測
    • 市場全體
    • 各材料
    • 各適應症
  • 促進成長要素與阻礙因素
    • 促進因素
    • 阻礙因素
  • 競爭分析

玻尿酸關節內補充藥市場

  • 簡介
  • 市場概要
    • 各注射循環
  • 市場分析、預測
    • 市場全體
    • 各注射循環
  • 促進成長要素與阻礙因素
    • 促進因素
    • 阻礙因素
  • 競爭分析

整形外科用成長因素市場

  • 簡介
  • 市場分析、預測
    • 整形外科用成長因素市場
  • 促進成長要素與阻礙因素
    • 促進因素
    • 阻礙因素
  • 競爭分析

附錄:國內競爭企業名錄

簡稱

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_CHOB20_MS

Throughout this medical market research, iData Research analyzed 28 orthobiologics companies in China and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the China Orthopedic Biomaterials market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an orthobiologics procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered:

1. Procedure Volumes for the China Orthopedic Biomaterials Devices - MedPro

2. Orthopedic Bone Graft Substitute Market - MedCore

3. Orthopedic Growth Factor Market - MedCore

4. Hyaluronic Acid Viscosupplementation Market - MedCore

China Orthopedic Biomaterials Market Insights

Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 12% of the Chinese population was aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.

In the past, lower tier hospitals (I and II) were primarily served by local manufacturers with relatively simple products at significantly lower prices than the products purchased by tier III hospitals, which were primarily supplied by international companies. Now, with the financial and regulatory support of the government, increasingly difficult entry barriers for international products and weak intellectual property protection that incentivizes product plagiarism, the market has shifted in favor of local manufacturers.

Overall, the China orthopedic biomaterials market was valued at $460.7 million in 2019. This is expected to increase over the forecast period at a CAGR of 6% to reach $690.8 million.

LIST OF CHARTS

  • Chart 1 1: Orthopedic Biomaterials Market by Segment, China, 2012 - 2022 2
  • Chart 1 2: Orthopedic Biomaterials Market Overview, China, 2015 & 2022 2
  • Chart 3 1: Orthopedic Biomaterials Market by Segment, China, 2012 - 2022 26
  • Chart 3 2: Orthopedic Biomaterials Market Breakdown, China, 2015 27
  • Chart 3 3: Orthopedic Biomaterials Market Breakdown, China, 2022 27
  • Chart 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, China, 2012 - 2022 29
  • Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, China, 2015 37
  • Chart 4 1: Bone Graft Substitute Procedures by Material, China, 2012 - 2022 43
  • Chart 4 2: Bone Graft Substitute Procedures by Indication, China, 2012 - 2022 46
  • Chart 4 3: Total Bone Graft Substitute Units Sold per Procedure by Indication (Excluding Autograft), China, 2012 - 2022 49
  • Chart 4 4: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, China, 2012 - 2022 51
  • Chart 4 5: Orthopedic Growth Factor Procedures, China, 2012 - 2022 53
  • Chart 5 1: Bone Graft Substitute Market by Material, China, 2012 - 2022 58
  • Chart 5 2: Bone Graft Substitute Market Breakdown by Material, China, 2015 59
  • Chart 5 3: Bone Graft Substitute Market Breakdown by Material, China, 2022 59
  • Chart 5 4: Bone Graft Substitute Market by Indication, China, 2012 - 2022 61
  • Chart 5 5: Bone Graft Substitute Market Breakdown by Indication, China, 2015 62
  • Chart 5 6: Bone Graft Substitute Market Breakdown by Indication, China, 2022 62
  • Chart 5 7: Total Bone Graft Substitute Market, China, 2012 - 2022 65
  • Chart 5 8: Allograft Bone Graft Substitute Market, China, 2012 - 2022 67
  • Chart 5 9: Demineralized Bone Matrix Market, China, 2012 - 2022 69
  • Chart 5 10: Synthetic Bone Graft Substitute Market, China, 2012 - 2022 71
  • Chart 5 11: Total Spine Market, China, 2012 - 2022 73
  • Chart 5 12: Cervical Spine Market, China, 2012 - 2022 75
  • Chart 5 13: Thoracolumbar Spine Market, China, 2012 - 2022 77
  • Chart 5 14: Trauma & Reconstruction Market, China, 2012 - 2022 79
  • Chart 5 15: Bone Tumor Market, China, 2012 - 2022 81
  • Chart 5 16: Bone Tumor Market, China, 2012 - 2022 83
  • Chart 5 17: Leading Competitors, Bone Graft Substitute Market, China, 2015 92
  • Chart 6 1: Hyaluronic Acid Viscosupplementation Market by Injection Cycle, China, 2012 - 2022 96
  • Chart 6 2: Hyaluronic Acid Viscosupplementation Market Breakdown, China, 2015 97
  • Chart 6 3: Hyaluronic Acid Viscosupplementation Market Breakdown, China, 2022 97
  • Chart 6 4: Total Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022 99
  • Chart 6 5: Three-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022 102
  • Chart 6 6: Five-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022 104
  • Chart 6 7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2015 111
  • Chart 7 1: Orthopedic Growth Factor Market, China, 2012 - 2022 115
  • Chart 7 2: Leading Competitors, Orthopedic Growth Factor Market, China, 2015 120